SELFEMRA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Selfemra, and what generic alternatives are available?
Selfemra is a drug marketed by Teva Pharms Usa and is included in one NDA.
The generic ingredient in SELFEMRA is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Selfemra
A generic version of SELFEMRA was approved as fluoxetine hydrochloride by APNAR PHARMA LP on August 2nd, 2001.
Summary for SELFEMRA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 174 |
Clinical Trials: | 1 |
Patent Applications: | 5,914 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SELFEMRA at DailyMed |
Recent Clinical Trials for SELFEMRA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Emory University | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for SELFEMRA
US Patents and Regulatory Information for SELFEMRA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Usa | SELFEMRA | fluoxetine hydrochloride | TABLET;ORAL | 200151-001 | Feb 3, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Usa | SELFEMRA | fluoxetine hydrochloride | TABLET;ORAL | 200151-002 | Feb 3, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Usa | SELFEMRA | fluoxetine hydrochloride | TABLET;ORAL | 200151-003 | Feb 3, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |